Our Discord Community (FREE): https://discord.com/invite/Efbjh7Qj4V 📚 Review our sources ►https://pastebin.com/iGUHi2eR 💻 Check out our other socials ► linktr.ee/2and20 ✋ Get in touch ► kamal@2and20media.com GLP-1 drugs like Ozempic are the fastest-growing drug class in history, with 50 million people expected to be on them by 2030. They don't just kill appetite. Studies show they reduce cravings for alcohol, nicotine, and even gambling. Jefferies estimates US airlines alone would save $580 million a year just from lighter passengers. But an annual course costs $15,000, Medicare won't cover it for weight loss, and the WHO says these drugs will reach less than 10% of the people who need them. In this video, we break down what the post-Ozempic economy actually looks like, who wins, who loses, and why the people who need it most are the last ones to get it. 00:00 - Intro 01:50 - Moderation Molecules 04:13 - The Skinny Economy 07:48 - The Price of Progress 12:13 - Ozempic for the Rich, Body Positivity for Everyone Else Includes music by Tom Fox – tomfox.site